{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:35:04Z","timestamp":1785407704011,"version":"3.56.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["2023-MSLH-388"],"award-info":[{"award-number":["2023-MSLH-388"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016807","name":"Natural Science Foundation of Shenyang Municipality","doi-asserted-by":"publisher","award":["22-321-33-20"],"award-info":[{"award-number":["22-321-33-20"]}],"id":[{"id":"10.13039\/100016807","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Outstanding Scientific Fund of Shengjing Hospital","award":["ME57"],"award-info":[{"award-number":["ME57"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Multiple acyl-coenzyme A (CoA) dehydrogenase deficiency (MADD) is an autosomal recessive disorder resulting from mutations in the <jats:italic>ETFDH<\/jats:italic> gene. It is characterized by a wide spectrum of clinical symptoms, of which polycystic kidney disease is a specific phenotype of early-onset MADD. This study aims to broaden the genetic mutation spectrum of <jats:italic>ETFDH<\/jats:italic> gene. And we clarify the pathogenic mechanism of polycystic kidney caused by the loss of function of the <jats:italic>ETFDH<\/jats:italic> gene through in vitro experiments.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Compound heterozygous variants in <jats:italic>ETFDH<\/jats:italic> (NM_004453: c.487\u2009+\u20092 T\u2009&gt;\u2009A, c.1395 T\u2009&gt;\u2009G and c.1773\u20131774 del AT(in cis with c.1395 T\u2009&gt;\u2009G) were identifed via trio-Whole Exome Sequencing (trio-WES) and confirmed pathogenic through Minigene Splice Assay and RT-PCR. This study, for the first time, demonstrated through both in vivo and in vitro experiments that c.487\u2009+\u20092 T\u2009&gt;\u2009A mutation lead to mRNA degradation through  nonsense-mediated decay (NMD). Further cell experiments showed that downregulation of <jats:italic>ETFDH<\/jats:italic> gene led to lipid accumulation, enhanced oxidative stress, and upregulation of ZNF267 expression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This study clarify the pathogenicity of c.487\u2009+\u20092 T\u2009&gt;\u2009A and c.1395 T\u2009&gt;\u2009G mutations, aiding in the diagnosis and genetic counseling of <jats:italic>ETFDH<\/jats:italic> in clinical practice. The significance of this study is to reveal that <jats:italic>ETFDH<\/jats:italic> gene may be a key regulatory gene in the development of polycystic kidney.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03640-4","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T16:58:11Z","timestamp":1741798691000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identification of ETFDH gene c. 487\u2009+\u20092 T\u2009&gt;\u2009A pathogenic variant and mechanisms for polycystic kidney in neonatal onset MADD"],"prefix":"10.1186","volume":"20","author":[{"given":"Bijun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"key":"3640_CR1","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13023-014-0117-5","volume":"9","author":"SC Gr\u00fcnert","year":"2014","unstructured":"Gr\u00fcnert SC. Clinical and genetical heterogeneity of late-onset multiple acyl-coenzyme A dehydrogenase deficiency. Orphanet J Rare Dis. 2014;9:117.","journal-title":"Orphanet J Rare Dis"},{"issue":"12","key":"3640_CR2","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1016\/j.bbabio.2010.10.007","volume":"1797","author":"NJ Watmough","year":"2010","unstructured":"Watmough NJ, Frerman FE. The electron transfer Flavoprotein: ubiquinone oxidoreductases. Biochim Biophys Acta. 2010;1797(12):1910\u20136.","journal-title":"Biochim Biophys Acta"},{"key":"3640_CR3","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.cca.2022.02.022","volume":"530","author":"B Zhang","year":"2022","unstructured":"Zhang B, Zhao Y. Novel variant of ETFDH leading to multiple acyl-CoA dehydrogenase deficiency by promoting protein degradation via ubiquitin proteasome pathway. Clin Chim Acta. 2022;530:104\u201312. https:\/\/doi.org\/10.1016\/j.cca.2022.02.022.","journal-title":"Clin Chim Acta"},{"issue":"5","key":"3640_CR4","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s10545-008-0990-y","volume":"31","author":"N Gregersen","year":"2008","unstructured":"Gregersen N, Andresen BS, Pedersen CB, Olsen RK, Corydon TJ, Bross P. Mitochondrial fatty acid oxidation defects\u2013remaining challenges. J Inherit Metab Dis. 2008;31(5):643\u201357.","journal-title":"J Inherit Metab Dis"},{"key":"3640_CR5","unstructured":"Prasun P. Multiple Acyl-CoA dehydrogenase deficiency. Seattle (WA); 1993."},{"issue":"1","key":"3640_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/humu.10226","volume":"22","author":"RK Olsen","year":"2003","unstructured":"Olsen RK, Andresen BS, Christensen E, Bross P, Skovby F, Gregersen N. Clear relationship between ETF\/ETFDH genotype and phenotype in patients with multiple acyl-CoA dehydrogenation deficiency. Hum Mutat. 2003;22(1):12\u201323.","journal-title":"Hum Mutat"},{"issue":"4","key":"3640_CR7","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1080\/10409238.2021.1908952","volume":"56","author":"S Missaglia","year":"2021","unstructured":"Missaglia S, Tavian D, Angelini C. ETF dehydrogenase advances in molecular genetics and impact on treatment. Crit Rev Biochem Mol Biol. 2021;56(4):360\u201372.","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"3640_CR8","first-page":"39","volume":"27","author":"C Pontoizeau","year":"2016","unstructured":"Pontoizeau C, Habarou F, Brassier A, et al. Hyperprolinemia in type 2 glutaric aciduria and MADD-Like profiles. JIMD Rep. 2016;27:39\u201345.","journal-title":"JIMD Rep"},{"issue":"19","key":"3640_CR9","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1002\/bdr2.1805","volume":"112","author":"A Martinez-Aracil","year":"2020","unstructured":"Martinez-Aracil A, Ruiz-Onandi R, Perez-Rodriguez A, Sagasta A, Llano-Rivas I, Perez de Nanclares G. Prenatal and foetal autopsy findings in glutaric aciduria type II. Birth Defects Res. 2020;112(19):1738\u201349.","journal-title":"Birth Defects Res"},{"issue":"5","key":"3640_CR10","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s00467-016-3556-5","volume":"32","author":"A Hackl","year":"2017","unstructured":"Hackl A, Mehler K, Gottschalk I, et al. Disorders of fatty acid oxidation and autosomal recessive polycystic kidney disease-different clinical entities and comparable perinatal renal abnormalities. Pediatr Nephrol. 2017;32(5):791\u2013800.","journal-title":"Pediatr Nephrol"},{"issue":"1\u20132","key":"3640_CR11","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S1096-7192(02)00138-5","volume":"77","author":"SI Goodman","year":"2002","unstructured":"Goodman SI, Binard RJ, Woontner MR, Frerman FE. Glutaric acidemia type II: gene structure and mutations of the electron transfer Flavoprotein:ubiquinone oxidoreductase (ETF:QO) gene. Mol Genet Metab. 2002;77(1\u20132):86\u201390.","journal-title":"Mol Genet Metab"},{"issue":"6","key":"3640_CR12","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00109-011-0725-7","volume":"89","author":"ZQ Wang","year":"2011","unstructured":"Wang ZQ, Chen XJ, Murong SX, Wang N, Wu ZY. Molecular analysis of 51 unrelated pedigrees with late-onset multiple acyl-CoA dehydrogenation deficiency (MADD) in Southern China confirmed the most common ETFDH mutation and high carrier frequency of c.250G\u2009>\u2009A. J Mol Med (Berl). 2011;89(6):569\u201376.","journal-title":"J Mol Med (Berl)"},{"issue":"5","key":"3640_CR13","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med"},{"issue":"2","key":"3640_CR14","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s42255-023-00956-y","volume":"6","author":"JC Herrero Mart\u00edn","year":"2024","unstructured":"Herrero Mart\u00edn JC, Salegi Ansa B, \u00c1lvarez-Rivera G, Dom\u00ednguez-Zorita S, Rodr\u00edguez-Pombo P, P\u00e9rez B, et al. An ETFDH-driven metabolon supports OXPHOS efficiency in skeletal muscle by regulating coenzyme Q homeostasis. Nat Metab. 2024;6(2):209\u201325. https:\/\/doi.org\/10.1038\/s42255-023-00956-y.","journal-title":"Nat Metab"},{"issue":"1","key":"3640_CR15","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/s42003-021-02730-w","volume":"4","author":"N Daneshgar","year":"2021","unstructured":"Daneshgar N, Baguley AW, Liang PI, et al. Metabolic derangement in polycystic kidney disease mouse models is ameliorated by mitochondrial-targeted antioxidants. Commun Biol. 2021;4(1):1200.","journal-title":"Commun Biol"},{"issue":"47","key":"3640_CR16","doi-asserted-by":"publisher","first-page":"49064","DOI":"10.1074\/jbc.M407715200","volume":"279","author":"FL Muller","year":"2004","unstructured":"Muller FL, Liu Y, Van Remmen H. Complex III releases superoxide to both sides of the inner mitochondrial membrane. J Biol Chem. 2004;279(47):49064\u201373.","journal-title":"J Biol Chem"},{"key":"3640_CR17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.freeradbiomed.2016.04.001","volume":"100","author":"MD Brand","year":"2016","unstructured":"Brand MD. Mitochondrial generation of superoxide and hydrogen peroxide as the source of mitochondrial redox signaling. Free Radic Biol Med. 2016;100:14\u201331.","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"3640_CR18","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.yexmp.2011.07.006","volume":"91","author":"B Schnabl","year":"2011","unstructured":"Schnabl B, Valletta D, Kirovski G, Hellerbrand C. Zinc finger protein 267 is up-regulated in hepatocellular carcinoma and promotes tumor cell proliferation and migration. Exp Mol Pathol. 2011;91(3):695\u2013701. https:\/\/doi.org\/10.1016\/j.yexmp.2011.07.006.","journal-title":"Exp Mol Pathol"},{"issue":"7","key":"3640_CR19","first-page":"661","volume":"4","author":"B Schnabl","year":"2011","unstructured":"Schnabl B, Czech B, Valletta D, Weiss TS, Kirovski G, Hellerbrand C. Increased expression of zinc finger protein 267 in non-alcoholic fatty liver disease. Int J Clin Exp Pathol. 2011;4(7):661\u20136.","journal-title":"Int J Clin Exp Pathol"},{"issue":"12","key":"3640_CR20","doi-asserted-by":"publisher","first-page":"152702","DOI":"10.1016\/j.prp.2019.152702","volume":"215","author":"Y Wu","year":"2019","unstructured":"Wu Y, Zhang X, Shen R, Huang J, Lu X, Zheng G, Chen X. Expression and significance of ETFDH in hepatocellular carcinoma. Pathol Res Pract. 2019;215(12):152702.","journal-title":"Pathol Res Pract"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03640-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03640-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03640-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T16:58:16Z","timestamp":1741798696000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03640-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,12]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3640"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03640-4","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,12]]},"assertion":[{"value":"16 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has obtained ethical approval from the Ethical Review Board of Shengjing Hospital of China Medical University(2024PS759K). Written informed consent was obtained from each participant in our study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conficts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"121"}}